Table 1 Baseline patients’ characteristics, n (%)
Variable | AG (n = 24) | FFX (n = 20) | P value |
|---|---|---|---|
Age (years) | |||
 Mean ± SD | 60.0 ± 9.2 | 55.9 ± 9.6 | 0.545 |
  < 60 | 11 (45.8) | 11 (55.0) | |
  ≥ 60 | 13 (54.2) | 9 (45.0) | |
Gender | |||
 Male | 18 (75.0) | 13 (65.0) | 0.469 |
 Female | 6 (25.0) | 7 (35.0) | |
Baseline CA19-9, U/mL | |||
 Normal (0–37) | 7 (29.2) | 6 (30.0) | 0.952 |
 Elevated (> 37) | 17 (70.8) | 14 (70.0) | |
 Baseline CEA, ng/mL | |||
 Normal (0–7.2) | 13 (54.2) | 14 (70.0) | 0.283 |
 Elevated (> 7.2) | 11 (45.8) | 6 (30.0) | |
Tumor site of pancreas | |||
 Head/neck | 13 (54.2) | 13 (65.0) | 0.467 |
 Body/tail | 11 (45.8) | 7 (35.0) | |
Number of metastasis | |||
 1 | 11 (45.8) | 9 (45.0) | 0.956 |
  ≥ 2 | 13 (54.2) | 11 (55.0) | |
Liver metastasis | |||
 Yes | 18 (75.0) | 12 (60.0) | 0.287 |
 No | 6 (25.0) | 8 (40.0) | |
Combined with radiotherapy | |||
 Yes | 9 (37.5) | 13 (65.0) | 0.069 |
 No | 15 (62.5) | 7 (35.0) | |
 PNI (prognostic nutrition index) | 43.55 ± 5.12 | 43.00 ± 5.08 | 0.635 |